ASH

Biotech By Adam Feuerstein

Vindicated. New J&J CAR-T myeloma data confirm strong efficacy, ease doubts raised by Chinese version

Biotech By Adam Feuerstein

Divergent results from Agios, Forma trials for their sickle cell disease drugs

Biotech By Matthew Herper

With new data and a storied history, Eli Lilly’s blood cancer pill is looking stronger

Biotech By Adam Feuerstein

Constellation’s blood cancer drug shows greater benefit, easing concerns about its future

Biotech By Adam Feuerstein

J&J’s CAR-T drug maintains strong efficacy in myeloma, shaded by neurotoxicity

Biotech By Adam Feuerstein

Genetically targeted drug from Kura Oncology induces remissions in adult leukemia patients

Biotech By Adam Feuerstein

Preliminary but ‘nothing short of great.’ New data on CRISPR treatment for blood diseases suggest cure is possible

Biotech By Adam Feuerstein

Bristol-Myers CMO on cell therapies: ‘This is the best time to be in drug development’